{"id":2462,"date":"2026-03-05T11:23:41","date_gmt":"2026-03-05T02:23:41","guid":{"rendered":"https:\/\/teamoncology.com\/echo\/86th-echo-one-clinic\/"},"modified":"2026-03-05T11:26:52","modified_gmt":"2026-03-05T02:26:52","slug":"86th","status":"publish","type":"page","link":"https:\/\/teamoncology.com\/en\/echo\/86th\/","title":{"rendered":"86th ECHO ONE Clinic"},"content":{"rendered":"\n
<\/span>
\n

86th ECHO ONE Clinic<\/h1>\n\n\n\n
\n
\n
Theme<\/span><\/dt>\n\n\n\n
\n

Management of cachexia<\/p>\n<\/div><\/dd>\n<\/div>\n\n\n\n

\n
Date and Time<\/span><\/dt>\n\n\n\n
\n

Monday, March 16th, 2026, 9 p.m. in Japan and Korea, 8 p.m. in Taiwan and the Philippines, 7 p.m. in Thailand and Vietnam, and 7 a.m. in Houston *About 1 Hour<\/p>\n<\/div><\/dd>\n<\/div>\n\n\n\n

\n
Language<\/span><\/dt>\n\n\n\n
\n

English *AI-powered live translated captions can be enabled for various languages within Zoom meetings.<\/p>\n<\/div><\/dd>\n<\/div>\n\n\n\n

\n
Organized by<\/span><\/dt>\n\n\n\n
\n

Project ECHO ONE Japan Team<\/p>\n<\/div><\/dd>\n<\/div>\n<\/dl>\n<\/div><\/div>\n

\n
\"\"<\/figure>\n<\/div>\n
<\/div>\n\n
\n
\n
Mentor<\/span><\/dt>\n\n\n\n
\n

Dr. Lara Magnabosco (Mayo Clinic)<\/p>\n<\/div><\/dd>\n<\/div>\n\n\n\n

\n
Case Presenter<\/span><\/dt>\n\n\n\n
\n

Dr. Haruka Ozaki (The Cancer Institute Hospital of JFCR)<\/p>\n<\/div><\/dd>\n<\/div>\n\n\n\n

\n
Commentator<\/span><\/dt>\n\n\n\n
\n

Dr. Ruey-Kun Shieh (Taiwan Total Cancer Care Foundation)Mr. Manit Saeteaw (Khon Kaen University)<\/p>\n<\/div><\/dd>\n<\/div>\n\n\n\n

\n
Facilitator<\/span><\/dt>\n\n\n\n
\n

Mr. Nicholas A Szewczyk (The University of Texas MD Anderson Cancer Center)Dr. Takahiro Kogawa (The Cancer Institute Hospital of JFCR)<\/p>\n<\/div><\/dd>\n<\/div>\n\n\n\n

\n
Participation Capacity<\/span><\/dt>\n\n\n\n
\n

100 People<\/p>\n<\/div><\/dd>\n<\/div>\n\n\n\n

\n
Participation Fee<\/span><\/dt>\n\n\n\n
\n

Free<\/p>\n<\/div><\/dd>\n<\/div>\n<\/dl>\n\n

\n

<\/p>\n<\/blockquote>\n\n

<\/i>
\n

Cachexia is a growing, under-recognized driver of frailty, treatment intolerance, and poor quality of life in older adults with cancer. This session highlights practical assessment and multidisciplinary management, and emerging therapies. We welcome oncologists, geriatricians, nurses, pharmacists, dietitians, rehab and palliative teams to join.<\/p>\n<\/div><\/div>\n\n

<\/div>\n\n

Registration Form<\/h2>\n\n